Imre Gonda

Imre Gonda

Auto-generated profile, based on publicly available information

Imre Gonda

Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Nature
Verified
Journal Article
Closed access
PDF file
FAFabian M. Arnold
Fabian M. Arnold
MWMiriam Sarah Weber
Miriam Sarah Weber
IGImre Gonda
Imre Gonda
MGMarc J. Gallenito
Marc J. Gallenito
SASophia Adenau
Sophia Adenau
MSMarkus A. Seeger
Markus A. Seeger

7 March 2022 in EMBO Reports
Verified
Journal Article
Open access
JWJustin D Walter
Justin D Walter
MSMelanie Scherer
Melanie Scherer
CHCedric A J Hutter
Cedric A J Hutter
AGAlisa A Garaeva
Alisa A Garaeva
IZIwan Zimmermann
Iwan Zimmermann
MSMarkus A Seeger
Markus A Seeger
The ongoing COVID‐19 pandemic represents an unprecedented global health crisis. Here, we report the identification of a synthetic nanobody (sybody) pair, Sb#15 and Sb#68, that can bind simultaneously to the SARS‐CoV‐2 spike RBD and efficiently neutralize pseudotyped and live viruses by interfering with ACE2 interaction. Cryo‐EM confirms that Sb#15 and Sb#68 engage two spatially discrete epitopes, influencing rational design of bispecific and tri‐bispecific fusion constructs that exhibit up to 100‐ and 1,000‐fold increase in neutralization potency, respectively. Cryo‐EM of the sybody‐spike complex additionally reveals a novel up‐out RBD conformation. While resistant viruses emerge rapidly in the presence of single binders, no escape variants are observed in the presence of the bispecific sybody. The multivalent bispecific constructs further increase the neutralization potency against globally circulating SARS‐CoV‐2 variants of concern. Our study illustrates the power of multivalency and biparatopic nanobody fusions for the potential development of therapeutic strategies that mitigate the emergence of new SARS‐CoV‐2 escape mutants.

1 May 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
GOGábor Orgován
Gábor Orgován
IGImre Gonda
Imre Gonda
BNBéla Noszál
Béla Noszál

29 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
IGImre Gonda
Imre Gonda
SSSimona Sorrentino
Simona Sorrentino
LGLaura Galazzo
Laura Galazzo
NLNicolas P. Lichti
Nicolas P. Lichti
FAFabian M. Arnold
Fabian M. Arnold
MSMarkus A. Seeger
Markus A. Seeger
The mycobacterial ABC transporter IrtAB features an ABC exporter fold, yet it imports iron-charged siderophores called mycobactins. Here, we present extensive cryo-EM analyses and DEER measurements, revealing that IrtAB alternates between an inward-facing and an outward-occluded conformation, but does not sample an outward-facing conformation. When IrtAB is locked in its outward-occluded conformation in nanodiscs, mycobactin is bound in the middle of the lipid bilayer at a membrane-facing crevice opening at the heterodimeric interface. Mutations introduced at the crevice abrogate mycobactin import and in corresponding structures, the crevice is collapsed. A conserved triple histidine motif coordinating a zinc ion is present below the mycobactin binding site. Substitution of these histidine residues with alanine results in a decoupled transporter, which hydrolyzes ATP, but lost its capacity to import mycobactins. Our data suggest that IrtAB imports mycobactin via a credit-card mechanism in a transport cycle that is coupled to the presence of zinc.

25 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSille Remm
Sille Remm
DVDario De Vecchis
Dario De Vecchis
JSJendrik Schöppe
Jendrik Schöppe
CHCedric A.J. Hutter
Cedric A.J. Hutter
IGImre Gonda
Imre Gonda
MSMarkus A. Seeger
Markus A. Seeger
Mycobacterium tuberculosis is protected from antibiotic therapy by a multi-layered hydrophobic cell envelope. Major facilitator superfamily (MFS) transporter Rv1410 and the periplasmic lipoprotein LprG are involved in transport of triacylglycerides (TAGs) that seal the mycomembrane. Here, we report a 2.7 Å structure of a mycobacterial Rv1410 homologue, which adopts an outward-facing conformation and exhibits unusual transmembrane helix 11 and 12 extensions that protrude ∼20 Å into the periplasm. A small, very hydrophobic cavity suitable for lipid transport is constricted by a unique and functionally important ion-lock likely involved in proton coupling. Combining mutational analyses and MD simulations, we propose that TAGs are extracted from the core of the inner membrane into the central cavity via lateral clefts present in the inward-facing conformation. The periplasmic helix extensions are crucial for lifting TAGs away from the membrane plane and channeling them into the lipid binding pocket of LprG.

21 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
IGImre Gonda
Imre Gonda
DJDaniel Junker
Daniel Junker
FEFabian Eggimann
Fabian Eggimann
AKAndres Kaech
Andres Kaech
PSPiotr Szwedziak
Piotr Szwedziak
Due to recent technological advances, in situ structural cell biology is becoming a high throughput microscopy technique as all the steps of the workflow, from sample preparation to data analysis, are executed faster, more reliable and more reproducible. Sample thinning by cryoFIB-SEM is an essential tool in preparing electron transparent lamellae of biological specimens suitable for further characterization by cryoET. Modern cryoFIB-SEM instruments can be operated remotely and are capable of automated and unsupervised lamellae preparation. To take full advantage of these developments they need a constant supply of LN₂ to maintain cryogenic conditions inside the microscope chamber. Here, we introduce a custom automated LN₂ refill system that is compatible with gas cooled cryostages, supports long-term cryoFIB-SEM operations and liberates the user from highly repetitive and manual work. We believe this solution can be utilized with other cryoSEM or cryoFIB-SEM devices requiring N2 gas-flow cooling and might be particularly beneficial in BSL-3 or BSL-4 laboratories where minimizing physical presence is essential for biosafety reasons.